Harbin Medical University

This early-phase trial tests a combination of two drugs (QL1706 and fruquintinib) in 18 adults with a specific type of advanced colorectal cancer that has not improved after at least two prior treatments. The goal is to see if the combination can shrink tumors or slow cancer grow…

This early-stage study tests a combination of three drugs (camrelizumab, pirfenidone, and chemotherapy) in 12 people with advanced triple-negative breast cancer that has not gotten worse after initial treatment. The goal is to see if the combination can shrink tumors or keep the …

This study tests whether an oral chemotherapy drug (paclitaxel) plus a targeted therapy (fruquintinib) can help adults with advanced stomach or gastroesophageal junction cancer that has worsened after first-line treatment. About 150 participants will be randomly assigned to recei…

This study tests whether a combination of two immunotherapy drugs (iparomlimab and tuvonralimab) plus a targeted drug (olaparib) and chemotherapy (paclitaxel) can eliminate cancer before surgery in 20 women with early high-risk triple negative breast cancer that has a specific ge…

This study looks at whether heart attack patients with mild artery narrowing can be treated with medication alone instead of getting a stent. About 2,000 people will be randomly assigned to either standard medication or medication plus a stent. The goal is to see if medication al…

This study tests whether using a special heart CT scan to guide intensive treatment can reduce major heart problems like heart attacks and strokes compared to standard care. About 15,000 high-risk adults aged 40-75 in rural China will take part. The goal is to see if this persona…

This study tests a mobile app called "Heart Voice: Starry Journey" designed to help parents and caregivers of children with autism feel more flexible and less anxious or depressed. About 52 caregivers will use the app for 6 weeks, while others continue their usual routine. The go…